Samit Hirawat - 01 Jul 2023 Form 4 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Role: EVP,Chief Med.Offr.,Drug Dev.
Signature: /s/ Lisa A. Atkins, attorney-in-fact for Samit Hirawat
Issuer symbol: BMY
Transactions as of: 01 Jul 2023
Transactions value $: -$306,129
Form type: 4
Filing time: 05 Jul 2023, 17:23:59 UTC
Previous filing: 14 Mar 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMY	Common Stock, $0.10 par value	Options Exercise	$0	+9,357	+21.93%	$0	52,032	01 Jul 2023	Direct	F1
transaction	BMY	Common Stock, $0.10 par value	Tax liability	-$306,128	-4,787	-9.2%	$63.95	47,245	01 Jul 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMY	Restricted Stock Units	Options Exercise	$0	-9,357	-100%	$0^*	0	01 Jul 2023	Common Stock, $0.10 par value	9,357		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units vest in four equal installments beginning on July 1, 2020.
F2	Shares withheld for payment of taxes upon vesting of restricted stock units.
F3	Each restricted stock unit converts into one share of common stock upon vesting.